ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com



2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬EMAÅú×¼ÎÀ²Ä·ÅÉäÐÔµâÄÑÖÎÐÔ¼××´ÏÙ°©Ò©ÎïÀÖ·¥ÌæÄá(Lenvatinib)¡£¡£¡£¡£¡£¡£ 2015Äê6ÔÂ2ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬EMAÅú×¼Helsinn»¯ÁÆËùÖ¶ñÐÄÍÂÄæÖÎÁƸ´·½Palonosetron(ÅÁÂåŵ˾Çí)+Netupitant(ÄÎÍ×ßÁ̹)¡£¡£¡£¡£¡£¡£ 2015Äê6ÔÂ4ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDA×ÉѯίԱ»á½¨ÒéÅú×¼SproutÅ®ÐÔÐÔ¹¦Ð§ÕϰҩÎïFlibanserin¡£¡£¡£¡£¡£¡£
Ò»¡¢ÐÂÒ©Åú×¼
1.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬EMAÅú×¼ÎÀ²Ä·ÅÉäÐÔµâÄÑÖÎÐÔ¼××´ÏÙ°©Ò©ÎïÀÖ·¥ÌæÄá(Lenvatinib)¡£¡£¡£¡£¡£¡£
2.2015Äê6ÔÂ2ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬EMAÅú×¼Helsinn»¯ÁÆËùÖ¶ñÐÄÍÂÄæÖÎÁƸ´·½Palonosetron(ÅÁÂåŵ˾Çí)+Netupitant(ÄÎÍ×ßÁ̹)¡£¡£¡£¡£¡£¡£
3.2015Äê6ÔÂ4ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDA×ÉѯίԱ»á½¨ÒéÅú×¼SproutÅ®ÐÔÐÔ¹¦Ð§ÕϰҩÎïFlibanserin¡£¡£¡£¡£¡£¡£
¶þ¡¢Í»ÆÆÐÔÁÆ·¨È϶¨
1.2015Äê6ÔÂ4ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓ轡ÔÞBÐÍÄáÂü-Æ¥¿ËÊϲ¡Ò©ÎïOlipudase alfaÍ»ÆÆÐÔÁÆ·¨È϶¨¡£¡£¡£¡£¡£¡£
Èý¡¢¿ìËÙͨµÀ
1.2015Äê6ÔÂ2ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬Ã÷ÖÎϸ¾úÐÔ·ÎÑ×Ò©ÎïME-1100(°¢±´¿¨ÐÇÎüÈë¼Á)½øÈëFDA¿ìËÙͨµÀ²¢»ñµÃQIDP×ʸñ¡£¡£¡£¡£¡£¡£
2.2015Äê6ÔÂ4ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬Retrophin·ºËἤøÒÀÀµÐÍÉñ¾ÍËÐÐÐÔ¼²²¡Ò©ÎïRE-024½øÈëFDA¿ìËÙͨµÀ¡£¡£¡£¡£¡£¡£
ËÄ¡¢ÓÅÏÈÉóÆÀ
1.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÜÀíĬ¿ËPembrolizumab¶þÏßÖÎÁÆ·ÇСϸ°û·Î°©sBLAÉêÇ룬£¬£¬£¬£¬£¬²¢ÊÚÓèÓÅÏÈÉóÆÀ×ʸñ£¬£¬£¬£¬£¬£¬PDUFAÈÕÆÚΪ2015Äê10ÔÂ2ÈÕ¡£¡£¡£¡£¡£¡£
2.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓè°ÙʱÃÀÊ©¹ó±¦NivolumabÁªºÏIpilimumabÒ»ÏßÖÎÁÆÍíÆÚ¶ñÐÔÐþÉ«ËØÁöÓÅÏÈÉóÆÀ×ʸñ¡£¡£¡£¡£¡£¡£
Îå¡¢¹Â¶ùÒ©
1.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓèMediciNova¿ËÀ²®²¡Ò©ÎïIbudilast¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£
2.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓèAptose Biosciences¼±ÐÔËèϸ°û°×Ѫ²¡Ò©ÎïAPTO-253¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£
3.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓèLipocineÔ¤·ÀÔç²úÒ©ÎïLPCN-1107¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£
4.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓèSancilio & Company¶Ì³¦×ÛºÏÕ÷Ò©Îï¶þÊ®¶þ̼ÁùÏ©Ëá¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£¸Ã¹«Ë¾¸´·½SC-401£¨¶þʮ̼ÎåÏ©Ëá+¶þÊ®¶þ̼ÁùÏ©ËᣩÕýÔÚÃÀ¹ú×ö¸ß¸ÊÓÍÈýõ¥ÑªÖ¢IIÆÚÁÙ´²¡£¡£¡£¡£¡£¡£
5.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬EMAÊÚÓèPranaºàÍ¢¶ÙÊÏÎ赸֢ҩÎïPBT-2¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£2014Äê9ÔÂ5ÈÕFDAÔøÊÚÓèÏàͬ×ʸñ¡£¡£¡£¡£¡£¡£
6.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓèApitope AÐÍѪÓѲ¡Ò©ÎïATX-F8-117¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£EMAÔøÓÚ2014Äê11ÔÂ25ÈÕÊÚÓèÏàͬ×ʸñ¡£¡£¡£¡£¡£¡£
7.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬EMAÊÚÓèStempeuticsѪ˨±ÕÈûÐÔÂö¹ÜÑ×Ò©ÎïStempeucel¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£
8.2015Äê6ÔÂ4ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓè°Ý¶ú¸Îϸ°û°©Ò©ÎïÈð¸ñ·ÆÄá(regorafenib)¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£
9.2015Äê6ÔÂ5ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÊÚÓèEdgeÒ½ÁÆÖëÍøÄ¤ÏÂÇ»³öѪҩÎïEG-1962¹Â¶ùÒ©×ʸñ¡£¡£¡£¡£¡£¡£
Áù¡¢NDA/BLA
1.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬¼ªÁеÂÒÑÏòFDAÌá½»IdelalisibÁªºÏOfatumumab¶þÏßÖÎÁÆÂýÐÔÁܰÍϸ°û°×Ѫ²¡µÄsNDAÉêÇë¡£¡£¡£¡£¡£¡£
2.2015Äê6ÔÂ1ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬FDAÒÑÊÜÀíElusysÒ½ÁÆObiltoxaximabÖÎÁÆÎüÈëÐÔÌ¿¾ÒµÄBLAÉêÇë¡£¡£¡£¡£¡£¡£
3.2015Äê6ÔÂ2ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬InsysÒÑÏòFDAÌá½»Çü´óÂé·Ó¿Ú·þÈÜÒºÉÏÊÐÉêÇë¡£¡£¡£¡£¡£¡£
4.2015Äê6ÔÂ3ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬ApaptÖÆÒ©ÒÑÏòFDAÌá½»±ÇÓÃÑÎËáÄÉÂåͪÉÏÊÐÉêÇë¡£¡£¡£¡£¡£¡£
5.2015Äê6ÔÂ3ÈÕÐÂÎÅ£¬£¬£¬£¬£¬£¬AmicusÒ½ÁÆÒÑÏòEMAÌá½»·¨²¼ÀﲡҩÎïMigalastatÉÏÊÐ